Print the pageFree Access Editorials
41.1
Computational Toxicology is Now Inseparable from Experimental Toxicology
Mark T.D. Cronin
40.6
FRAME and the Pharmaceutical Industry
Michael Balls
40.5
Where does iPS Cell Technology Leave the Promoters of the Creation and Use of Admixed Animal–Human Embryos?
Michael Balls
40.4
The Conflict over Animal Experimentation: Is the Field of Battle Changing?
Michael Balls
40.3
The International Transport of Laboratory Animals: No Excuse for Biased Extremism of Any Kind
Michael Balls
40.2
Ban on the Use of Great Apes as Laboratory Animals in the UK
Michael Balls
40.1
China is Taking Steps Toward Alternatives to Animal Testing
Rodger Curren and Brian Jones
39.6
Animal Experimentation and the Labelling of Drugs
Michael Balls
39.5
Toxicity Testing: The Need for New Maps for the Future
Michael Balls
39.4
The Three Rs and Animal Experimentation — Documented Signs of Advancement, or of Stagnation?
Michael Balls
39.3
Animal Experiments and Alternatives: Matters of Belief and Trust
Michael Balls
39.2
Modern Alternative Approaches to the Problem of Drug-induced Livery Injury
Michael Balls
39.1
Replacing Animal Experimentation: On Creating the Puzzles to be Solved
Michael Balls
38.6
ATLA (Alternatives to Laboratory Animals): Past, Present and Future
Michael Balls
38.5
The EU Commission’s Draft Report on Alternative (Nonanimal) Methods for Cosmetics Testing: Current Status and Future Prospects — 2010: A Missed Opportunity
Horst Spielmann
38.4
ATLA — A Truly International Journal
Rita Seabra and Susan Trigwell
38.3
Alternative Methods: Servants of Two Masters
Michael Balls
38.2
Adult Human Stem Cells and Toxicity Testing: Realising the Potential
Michael Balls
38.1
Replacing the Animal Testing of Botulinum Toxin: Time to Smooth Out the Wrinkles
Michael Balls
37.6
Replacing, Reducing and Refining Animal Experiments: Making Sound Progress, but Must Do Better
Michael Balls
37.5
In Silico Toxicology Challenges for Pharmaceuticals: Complacency or Controversy?
Mark T.D. Cronin
37.4
21st centry drug development: advances, opportunities and challenges
Nirmal Bhogal
37.3
Animal experimentation and the Three Rs: time for honest answers to some leading questions
Michael Balls
37.2
Refinement: a sense of progress
M. Jennings
37.1
Fifty years after Russell and Burch, toxicologists continue to ignore genetic variation in their test animals.
M.F.W. Festing
36.6
Animal Experimentation: Weighing the Benefits Against the Suffering
Michael Balls
36.5
Animal–human hybridisation: progressing down the slippery slope
Michael Balls
36.4
Advocates of Animal Experimentation: What’s in a Name?
Michael Balls
36.3
Experiments on humans and animals: can the end justify the means?
Michael Balls
36.2
The Production of Admixed Animal–Human Embryos: Is it Necessary, or Merely Desirable?
Michael Balls
36.1
Animal experimentation: the need for deliberation and challenge
S. Festing